Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2010 | 06-2010 | 12-2009 | 06-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,980 | 13,340 | 18,400 | 24,930 | 29,640 |
| Receivables | 2,310 | 1,740 | 2,560 | 1,680 | 3,670 |
| Inventories | 880 | 1,370 | 1,370 | 990 | 1,670 |
| Other current assets | 370 | 410 | 390 | 440 | 270 |
| TOTAL | $12,540 | $16,860 | $22,720 | $28,040 | $35,250 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $12,640 | $17,010 | $22,950 | $28,300 | $35,570 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,830 | 4,730 | 3,720 | 6,020 | 4,860 |
| Other current liabilities | 330 | 520 | 650 | 570 | 530 |
| TOTAL | $5,170 | $5,250 | $4,380 | $6,600 | $5,390 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 330 | 130 | 110 | 170 | 260 |
| TOTAL | $330 | $130 | $110 | $170 | $260 |
| Total Liabilities | $5,510 | $5,390 | $4,490 | $6,780 | $5,650 |
| Shareholders' Equity | |||||
| Common Shares | 203,880 | 182,060 | 187,510 | 154,400 | 138,620 |
| Retained earnings | -193,140 | -172,190 | -168,370 | -136,680 | -114,880 |
| Other shareholders' equity | -3,610 | 1,750 | -690 | 3,800 | 6,170 |
| TOTAL | $7,130 | $11,620 | $18,450 | $21,520 | $29,910 |
| Total Liabilities And Equity | $12,640 | $17,010 | $22,940 | $28,300 | $35,560 |